NDC 76420-920
Hydroxyzine Pamoate 25 mg capsule
On the label: Asclemed USA, Inc.. It's repackaged: Asclemed USA, Inc. rebottles it from Teva Pharmaceuticals USA, Inc.'s NDC 0555-0323.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Teva Pharmaceuticals USA, Inc. names for other drugs.
Repackaging site
- Asclemed USA Inc. dba Enovachem, Torrance, CA, United States · repackages it and relabels it
Recalls
- Jan 24, 2014 · Class II · Teva Pharmaceuticals USA
CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.
Lots: Lot # 34017426A, Exp. 10/16. - Jan 24, 2014 · Class II · Teva Pharmaceuticals USA
CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.
Lots: Lot # 34016752A, Exp. 09/16. Lot # 34016753A, Exp. 09/16.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Hydroxyzine: every company that makes it
- Form
- capsule, oral
- Strength
- 25 mg
- Approval
- ANDA ANDA088496
- On the market since
- Jul 1, 1984
- Package NDCs
76420-920-0176420-920-0576420-920-3076420-920-6076420-920-90- Official label
- DailyMed (National Library of Medicine), updated Feb 17, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?